PCSK9 and diabetes mellitus: While these results differ from the detrimental phenotype observed in constitutive Pcsk9 deficiency, they highlight that pharmacological inhibition in adulthood, acting primarily in the circulation and liver, may have context-dependent neuroprotective effects in acquired neuropathies such as diabetes.